Clinical Trial Update: One-Month DAPT in CABG Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is currently recruiting to evaluate one-month dual antiplatelet therapy in patients undergoing coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Chronic Coronary Disease | Phase 3 | Status: RECRUITING